Cutler Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-100
| Closed | -$1K | – | 4532 |
|
|
2023
Q2 | $1K | Buy |
+100
| New | +$3.53K | ﹤0.01% | 3481 |
|
|
2023
Q1 | – | Sell |
-8,600
| Closed | -$1K | – | 5025 |
|
|
2022
Q4 | $1K | Sell |
8,600
-23,200
| -73% | -$495K | ﹤0.01% | 4251 |
|
|
2022
Q3 | $44K | Buy |
+31,800
| New | +$417K | ﹤0.01% | 1995 |
|
|
2022
Q2 | – | Sell |
-29,900
| Closed | -$49K | – | 5947 |
|
|
2022
Q1 | $49K | Buy |
29,900
+28,700
| +2,392% | +$424K | ﹤0.01% | 2271 |
|
|
2021
Q4 | $3K | Sell |
1,200
-54,800
| -98% | -$898K | ﹤0.01% | 4622 |
|
|
2021
Q3 | $88K | Buy |
+56,000
| New | +$609K | ﹤0.01% | 2033 |
|
|
2020
Q1 | – | Sell |
-1,900
| Closed | -$3K | – | 4856 |
|
|
2019
Q4 | $3K | Buy |
+1,900
| New | +$6.79K | ﹤0.01% | 3360 |
|
|
2018
Q3 | – | Sell |
-5,100
| Closed | -$1K | – | 4887 |
|
|
2018
Q2 | $1K | Buy |
+5,100
| New | +$14.1K | ﹤0.01% | 4030 |
|
|
2017
Q4 | – | Sell |
-6,300
| Closed | -$1K | – | 6209 |
|
|
2017
Q3 | $1K | Sell |
6,300
-400
| -6% | -$1.08K | ﹤0.01% | 5623 |
|
|
2017
Q2 | $1K | Sell |
6,700
-14,300
| -68% | -$39K | ﹤0.01% | 6113 |
|
|
2017
Q1 | $16K | Sell |
21,000
-109,100
| -84% | -$461K | ﹤0.01% | 3581 |
|
|
2016
Q4 | $10K | Buy |
130,100
+73,700
| +131% | +$2.19M | ﹤0.01% | 4249 |
|
|
2016
Q3 | $402K | Buy |
56,400
+46,900
| +494% | +$2.64M | 0.02% | 723 |
|
|
2016
Q2 | $74K | Sell |
9,500
-3,900
| -29% | -$194K | ﹤0.01% | 1978 |
|
|
2016
Q1 | $27K | Buy |
13,400
+6,400
| +91% | +$326K | ﹤0.01% | 2980 |
|
|
2015
Q4 | $51K | Buy |
+7,000
| New | +$405K | ﹤0.01% | 2443 |
|
Cutler Group's ISEE Position: Q2 2023 in Review
Cutler Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 300 shares — an estimated $10.6K sold.
Cutler Group first reported a position in ISEE in Q4 2015 and held it in 21 quarters. The position peaked at $1.27M in Q3 2016. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- Cutler Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Cutler Group sold 300 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $10.6K.
- Cutler Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 21 quarters.
- Cutler Group's IVERIC bio, Inc. Common Stock position peaked at $1.27M in Q3 2016.
- 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.